Alto Neuroscience (ANRO) Other financing activities (2023 - 2025)

Alto Neuroscience has disclosed Other financing activities across 3 years of filings, most recently posting $127000.0 for Q1 2025.

• Other financing activities for Q1 2025 came in at $127000.0, down 97.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $127000.0 (changed N/A YoY), and the FY2025 annual result was $127000.0, changed N/A from the prior year.
• Other financing activities came in at $127000.0 for Q1 2025 at Alto Neuroscience, up from -$4.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $4.6 million in Q1 2024 to a low of -$4.6 million in Q2 2024.
• The 3-year median for Other financing activities is $140500.0 (2023), against an average of $46833.3.
• Peak annual rise in Other financing activities reached 2914.94% in 2024, while the deepest fall reached 2914.94% in 2024.
• Alto Neuroscience's Other financing activities stood at $154000.0 in 2023, then tumbled by 3114.94% to -$4.6 million in 2024, then surged by 102.74% to $127000.0 in 2025.
• The last three Other financing activities figures came in at $127000.0 (Q1 2025), -$4.6 million (Q2 2024), and $4.6 million (Q1 2024), per Business Quant data.